14 research outputs found

    Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection

    Get PDF
    International audienceTwo of the crucial aspects of human immunodeficiency virus (HIV) infection are (i) viral persistence in reservoirs (precluding viral eradication) and (ii) chronic inflammation (directly associated with all-cause morbidities in antiretroviral therapy (ART)-controlled HIV-infected patients). The objective of the present study was to assess the potential involvement of adipose tissue in these two aspects. Adipose tissue is composed of adipocytes and the stromal vascular fraction (SVF); the latter comprises immune cells such as CD4+ T cells and macrophages (both of which are important target cells for HIV). The inflammatory potential of adipose tissue has been extensively described in the context of obesity. During HIV infection, the inflammatory profile of adipose tissue has been revealed by the occurrence of lipodystrophies (primarily related to ART). Data on the impact of HIV on the SVF (especially in individuals not receiving ART) are scarce. We first analyzed the impact of simian immunodeficiency virus (SIV) infection on abdominal subcutaneous and visceral adipose tissues in SIVmac251 infected macaques and found that both adipocytes and adipose tissue immune cells were affected. The adipocyte density was elevated, and adipose tissue immune cells presented enhanced immune activation and/or inflammatory profiles. We detected cell-associated SIV DNA and RNA in the SVF and in sorted CD4+ T cells and macrophages from adipose tissue. We demonstrated that SVF cells (including CD4+ T cells) are infected in ART-controlled HIV-infected patients. Importantly, the production of HIV RNA was detected by in situ hybridization, and after the in vitro reactivation of sorted CD4+ T cells from adipose tissue. We thus identified adipose tissue as a crucial cofactor in both viral persistence and chronic immune activation/inflammation during HIV infection. These observations open up new therapeutic strategies for limiting the size of the viral reservoir and decreasing low-grade chronic inflammation via the modulation of adipose tissue-related pathway

    A New Fire Hazard for MR Imaging Systems: Blankets—Case Report

    Get PDF
    International audienceIn this report, a case of fire in a positron emission tomography(PET)/magnetic resonance (MR) imaging systemdue to blanket combustion is discussed. Manufacturingcompanies routinely use copper fibers for blanket fabrication,and these fibers may remain within the blanket hem.By folding a blanket with these copper fibers within anMR imaging system, one can create an electrical currentloop with a major risk of local excessive heating, burninjury, and fire. This hazard applies to all MR imagingsystems. Hybrid PET/MR imaging systems may be particularlyvulnerable to this situation, because blankets arecommonly used for fluorodeoxyglucose PET to maintain anormal body temperature and to avoid fluorodeoxyglucoseuptake in brown adipose tissue

    New-Onset Diabetes and Antiretroviral Treatments in HIV-Infected Adults in Thailand

    No full text
    BACKGROUND: Use of several antiretrovirals (ARVs) has been shown to be associated with a higher risk of diabetes in HIV-infected adults. We estimated the incidence of new-onset diabetes and assessed the association between individual ARVs and ARV combinations, and diabetes in a large cohort in Thailand. METHODS: We selected all HIV-1-infected, nondiabetic, antiretroviral-naive adults enrolled in the Program for HIV Prevention and Treatment cohort (NCT00433030) between January 2000 and December 2011. Diabetes was defined as confirmed fasting plasma glucose >/= 126 mg/dL or random plasma glucose >/= 2 00 mg/dL. Incidence was the number of cases divided by the total number of person-years of follow-up. Association between ARVs and ARV combinations, and new-onset diabetes was assessed using Cox proportional hazards models. RESULTS: Overall, 1594 HIV-infected patients (76% female) were included. Median age at antiretroviral therapy initiation was 32.5 years. The incidence rate of diabetes was 5.0 per 1000 person-years of follow-up (95% confidence interval: 3.8 to 6.6) (53 cases). In analyses adjusted for potential confounders, exposure to stavudine + didanosine [adjusted hazard ratio (aHR) = 3.9; P = 0.001] and cumulative exposure >/= 1 year to zidovudine (aHR = 2.3 vs. no exposure; P = 0.009) were associated with a higher risk of diabetes. Conversely, cumulative exposure >/= 1 year to tenofovir (aHR = 0.4 vs. no exposure; P = 0.02) and emtricitabine (aHR = 0.4 vs. no exposure; P = 0.03) were associated with a lower risk. CONCLUSIONS: The incidence of diabetes in this predominantly female, young, lean population was relatively low. Although stavudine and didanosine have now been phased out in most antiretroviral therapy programs, our analysis suggests a higher risk of diabetes with zidovudine, frequently prescribed today in resource-limited settings

    HIV RNA production following <i>in vitro</i> reactivation.

    No full text
    <p>Total SVF (filled circles), sorted CD4<sup>+</sup>CD3<sup>+</sup> (filled squares) and CD14<sup>+</sup>CD206<sup>+</sup> cells (filled triangles) from adipose tissue, and sorted CD4<sup>+</sup>CD3<sup>+</sup> (open squares) and CD14<sup>+</sup> cells (open triangles) from PBMCs were co-cultured with allogeneic, pre-activated CD4<sup>+</sup> T cells and then stimulated. The cell number differed according to the cell fraction: 1x10<sup>6</sup> for the total SVF fraction, 1x10<sup>5</sup> to 5x10<sup>5</sup> for sorted CD4<sup>+</sup> T cells, and 5x10<sup>4</sup> to 2x10<sup>5</sup> for sorted, CD14-expressing cells. HIV RNA was detected in supernatants collected at D7, 11, 14, 17 and 21. As a negative control, 1x10<sup>6</sup> SVF cells were cultured in the absence of allogeneic, pre-activated CD4<sup>+</sup> T cells (Ns SVF open circles). Samples from six ART-treated HIV infected patient were tested and the HIV RNA detection assay was performed five times for each sample.</p

    Localization of T cells in the adipose tissue of SIV-infected animals.

    No full text
    <p>Immunochemical analyses were performed on 11 SCAT and 10 VAT of SIV-infected animals. (A) Representative tissue sections showing CD4<sup>+</sup> T cells within fat and far from capillaries (upper) and TiA1<sup>+</sup> cells in the vicinity of the capillaries (lower). Scale bar: 50 μm, magnification x640 for CD4, x500 for TiA1. (B) Percentages of CD4<sup>+</sup> T cells (open diamonds) and CD8<sup>+</sup> T cells (filled diamonds) far from capillaries, corresponding to adipose-resident lymphocyte subsets. Depending on the location, cells were counted after immunochemical staining on SCAT and VAT sections from SIV-infected animals. Data are quoted as the median [interquartile range]. Significant differences in a Mann-Whitney non-parametric test are shown as ** p<0.01.</p

    Detection of HIV DNA and RNA in adipose tissue.

    No full text
    <p>(A) Detection of HIV DNA in SVF cells and PBMCs from 11 ART-treated, HIV-infected patients. Each patient is represented by a symbol, and the shading represents the type of adipose tissue: SCAT (open symbols), VAT (filled symbols). (B) HIV DNA detection in sorted CD4<sup>+</sup> T cells recovered from adipose tissue and PBMCs from 3 ART-treated, HIV-infected patients. The HIV DNA detection assay was performed in duplicate and is expressed in log copies per million cells. The detection limit differed as a function of the numbers of cells tested and is indicated as </p><dl>in situ hybridization assay for HIV RNA was performed on three samples of adipose tissue recovered from ART-treated, HIV-infected patients (1 VAT and 2 SCAT samples). Positive control: a prostate tissue sample from a viremic patient. One slide was analyzed for each sample. HIV RNA staining for each positive patient is shown. Scale bar: 50 μm.<p></p></dl

    The influence of SIV infection on T cell differentiation and activation status.

    No full text
    <p>(A) The naïve and memory CD4<sup>+</sup> T cell subset distribution in SCAT and VAT from SIV-infected or non-infected animals. Representative dot plots showing the gating strategies used to define Tn, Tcm, Ttm and Tem subsets among the CD4<sup>+</sup> T cells, based on CD28, CD95 (upper dot plot, SCAT and VAT samples). CCR5 expression and the FMO profile in CD28+CD95+ fractions are shown (lower dot plot: VAT sample). The right-hand panels show the distribution of CD4<sup>+</sup> T cells among the various subsets in non-infected animals (n = 5, open column) and SIV-infected animals (n = 7, filled column). (B) CD69 expression on CD4<sup>+</sup> T cells recovered from SCAT, VAT and PBMCs from SIV-infected or non-infected animals. Representative dot plots for SCAT and VAT (left panel) and the percentages of CD69-expressing CD4<sup>+</sup> T cells in SCAT, VAT and PBMCs from non-infected animals (n = 6, open columns) and SIV-infected animals (n = 7, filled columns) are shown. (C) HLA-DR expression on SCAT, VAT and PBMCs from SIV-infected or non-infected animals. Representative histograms showing HLA-DR expression on adipose-resident CD4<sup>+</sup> and CD8<sup>+</sup> T cells recovered from SCAT from non-infected (left panel) and SIV-infected animals (right-hand panel). HLA-DR expression histograms are shown in plain histogram. FMO staining (open histograms) was used to define the gating strategy. The percentage of HLA-DR-expressing cells among CD4<sup>+</sup> and CD8<sup>+</sup> T cells recovered from SCAT, VAT and PBMCs from non-infected animals (n = 6, open circles) and SIV-infected animals (n = 4–8, filled squares). Data are quoted as the median [interquartile range]. Significant differences in a Mann-Whitney non-parametric test are shown as * p<0.05; ** p<0.01.</p

    The influence of SIV infection on adipose-resident T cell subsets.

    No full text
    <p>(A) Percentages and numbers (expressed per gram of adipose tissue recovered) of CD3-expressing cells among the CD45<sup>+</sup> fraction from SCAT and VAT in non-infected animals (open circles) and SIV-infected animals (filled squares). Percentages were derived for 12 to 13 animals per group and counts were derived for 8 to 12 animals. (B) Representative dot plots showing CD4 and CD8 expression among CD3<sup>+</sup> T cells in SIV-infected and non-infected animals. (C) Percentages and numbers (expressed per gram of adipose tissue) of CD4- and CD8-expressing cells among CD3<sup>+</sup> cells recovered from SCAT and VAT of non-infected animals (open circles) and SIV-infected animals (filled squares). Percentages were derived for 8 to 12 animals per group and counts were derived for 5 to 8 animals. Data are quoted as the median [interquartile range]. Significant differences in a Mann-Whitney non-parametric test are shown as * p<0.05; ** p<0.01; *** p<0.001.</p
    corecore